MTVA MetaVia Inc.
MetaVia Inc. (MTVA) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.93 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -8.8% since its last earnings release on November 13, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About MetaVia Inc.
MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc., formerly known as NeuroBo Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.
Sector
Healthcare
Industry
Biotechnology
Charts powered in part by Lightweight Charts™ by TradingView.